News & Events


March 7, 2023

Halteres Associates Launches Halteres Presents Podcast Series

Exclusive Interviews with Experts in the Diagnostics Field to Bolster the Global Dialogue on Diagnostic & Life Science Matters

SAN RAMON, Calif.--(BUSINESS WIRE)--Halteres Associates, a leading bioscience consultancy that provides strategic and tactical services in the areas of diagnostics, medical devices, and life science research to clients of all sizes, today has launched season one of their new podcast series, Halteres Presents. The series, co-hosted by Halteres Associates partners Rich Thayer and Mickey Urdea, is described as a brand-agnostic interview podcast that seeks to provide an impartial perspective on the latest developments in medical diagnostics.

“As the Roman saying goes: ‘A wise man learns from the mistakes of others; a fool learns from his own.’”

Tweet this

Selections from the upcoming season of Halteres Presents include:

  • A three-episode series premiere focusing on tuberculosis diagnostics worldwide, featuring perspectives from Dr. Morten Ruhwald, Dr. Peter Small, and Dr. Shibu Vijayan, who are all prominent tuberculosis experts and experienced practitioners in the field;
  • A chat with Dr. Paul Keim, known for his work assisting the FBI's manhunt in response to the 2001 anthrax letters, and featured in the recent noteworthy Netflix documentary "The Anthrax Attacks", to discuss his essential and pivotal scientific research used in the investigation;
  • A discussion with Jen Leib, an experienced government affairs official from iPolicy Solutions, dissecting several key pieces of legislation related to the diagnostics industry and where they stand today;
  • An interview with Dr. Nancy Gagliano, Deployment Lead for the National Institute of Health’s (NIH) Rapid Acceleration of Diagnostics (RADx) initiative to speed innovation in COVID-19 diagnostics;
  • And a sit down with Mike Richey, Co-Chair of the Board of Directors of The National AIDS Memorial, to cover the obstacles to healthcare access for patients from all parts of the globe and all socio-economic backgrounds.

“We noticed a lack of opportunities within the diagnostics media landscape for prominent individuals to exchange knowledge directly with their colleagues, beyond traditional journals and conferences, or for other listeners to enrich their understanding of key issues influencing the availability of new testing solutions,” stated Halteres managing partner Rich Thayer. “We wanted to create our own sandbox where experts could come share their insights, experiences, forecasts, and observations beyond simply a high-level overview.”

Founding partner Mickey Urdea added that the aim of the podcast is to provide a platform for guests to share their extensive experience and insights, with the ultimate goal of driving the conversation around diagnostics forward for both experts and novices. “By codifying these lessons learned, we’re helping others to avoid the same pitfalls in their own journeys,” said Urdea. “As the Roman saying goes: ‘A wise man learns from the mistakes of others; a fool learns from his own.’”

New episodes of season one of Halteres Presents will be released weekly on Apple and Spotify. Season two is already in the works and is set to be released later in 2023.

Apple Podcasts Link:

Spotify Link:

About Halteres Associates

Founded in 2002, San Ramon-based Halteres Associates, LLC, provides strategic and tactical consulting services to organizations in the areas of diagnostics, global health, medical devices, and life science research. With decades of combined experience and leveraging a robust network of industry professionals across multiple disciplines, Halteres Associates assists organizations with technology creation and applications, product and market development, opportunity and economic analyses, business modeling, and more. Their clients include large multinational companies, global nongovernmental organizations, and emerging industry innovators.


Sharon Noot


October 27, 2022 -  Mickey Urdea is pleased to be delivering an in-person keynote presentation at the ASU Diagnostics Summit next week on Thursday, October 27th at the ASU Health Futures Center in Phoenix, Arizona (and on Zoom). The summit brings together leaders from academia, industry, and government to discuss, debate, and decide the issues most relevant to diagnostics. The meeting will explore the following topics in the field of diagnostics:

  • How does diagnostic regulation and reimbursement change for at-home testing?
  • Where does intellectual property for diagnostics go in the future?
  • Living in a post-COVID-19 world: What role does diagnostics play?

Register HERE to attend via Zoom or in-person!

September 21-23, 2022 Halteres Associates will be represented at the “28th AACC International CPOCT Symposium: Meeting Evolving Patient Needs Using Point-of-Care Testing” in Montreal, Canada, from September 21st – 23rd! The symposium promises to deliver stimulating discussions on the latest science and cutting-edge technological advances through a keynote lecture, scientific sessions, panel discussions, and interactive poster receptions.  Register to join us here:

May 7, 2022  Mickey Urdea is being presented with an honorary doctorate from his undergraduate alma mater, Northern Arizona University, and he is pleased to be delivering one of their commencement addresses!

For more information on NAU’s commencement ceremonies, click here:, and if you would like to watch Mickey's speech LIVE this Saturday 5/7 at 3pm PST, click here:

March, 21, 2022 Mickey Urdea will be presenting virtually at SelectBio’s "Rapid Diagnostic Testing 2022: SARS-CoV-2 and Beyond" Conference. The in-person conference will be held at the Wyndham Boston Beacon Hill, and Halteres Associates’s video production team will be present capturing the conference live!

March 1-2, 2022 Dr. Mickey S. Urdea will be presenting at the SelectBIO’s conference on “Microfluidics to Address Pandemics – SARS-CoV-2 and Beyond”, which takes place in the Netherlands March 1st-2nd, 2022.

This 2-day conference held onsite as a regular physical conference at the Hilton Rotterdam, The Netherlands, takes a deep dive on the current role of Microfluidics Technologies in SARS-CoV-2 testing (circa 2022) and expectations for the future role of Microfluidics in the Management of Pandemics.  The conference brings together companies engaged in this space from the larger diagnostics companies to the emerging companies providing technical solutions in this field -- providing them a platform to present their technology/offering to the community and engage.  In addition to presentations, there will be posters to highlight technologies and late-breaking developments.  This conference is chaired by Dr. Holger Becker, Chief Scientific Officer and Co-Founder of microfluidic ChipShop GmbH and a key opinion leader in the microfluidics and lab-on-a-chip field.


Pivot to Video Halteres Associates has published a new article blending Darwin’s “On the Origin of Species” with video production in biotech - “Pivot to Video: On The Origin of Views by Means of Video, or the Preservation of Favoured Companies in the Struggle for Engagement - and What That Means for the Diagnostics Industry”. Click here to read the article.

April 13, 2021 Dr. Mickey S. Urdea and Mr. Rich Thayer will be presenting at the Pandemic Influenza Preparedness (PIP) Framework for the Sharing influenza viruses & access to vaccines and other benefits — Briefing Session for AdvaMedDX Influenza Diagnostic Manufacturers.

Video Production The Halteres Associates video production team has wrapped another video production project! Many clients have asked what exactly goes into a day on set, so here is a peek behind the scenes! Click here to see the video.

While the finished product always looks crisp and polished, it takes a whole crew working in unison on set to accomplish what you see on the screen. The Halteres Associates video production team is composed of industry veterans who maximize efficiency while maintain the highest production quality. With this experienced crew, we can get a LOT done in a day.


November 10, 2020  Dr. Mickey S. Urdea is an invited speaker at the University of California QB3 webinar, “A Commercial Backlash in COVID-19 Diagnostics? Historical Lessons Including Ebola.” The demand for rapid, accessible COVID-19 testing has driven more than a thousand companies to develop over 1800 diagnostic tests. Which solutions will meet commercial success depends on many factors including technology, use case, scalability, and of course cost. One or two years from now, which companies will stand strong, while their would-be competitors regroup or fail? Following his talk, one-on-one sessions are available with Mickey. Register here:

September 2020   Dr. Mickey Urdea and Mr. Rich Thayer of Halteres Associates are authors on a recently published BMJ Innovations article entitled "Post-Mortems on Diagnostic Testing Start-ups: Reports of Commercial Successes and Failures and the Case of the Zombie Life Science Company." This article provides an in depth exploration of 28 diagnostics companies that were categorized as successful, failed, or zombies (companies have achieved financial solvency but without long-term viability). A five-phase framework was developed to generate a score that could predict diagnostic companies more likely to successfully and sustainably enter the market from those more likely to fail.

BMJ Innovations ( is a peer-reviewed online journal that publishes basic, clinical, translational, and epidemiological studies of all aspects of medical innovations. The journal champions research that offers new, cost-effective medical devices, technologies, processes and systems that improve patient care. It aims to promote innovations that make healthcare accessible and affordable, creating a community that aspires to make the world a healthier place.

July 14, 2020 Dr. Mickey S. Urdea is an invited speaker at the Cambridge Healthtech Institute's (CHI) breakOut free webinar series, “Testing for COVID-19 and Beyond”. The CHI breakOut webinars are focused on connecting the life science community to advance COVID-19 diagnostics and therapeutics. Register at this link:

June 4, 2020, Webinar hosted by PATH.
Mr. Rich Thayer is an invited speaker for the webinar, "Securing the Supply of COVID-19 Diagnostics".
Access to quality diagnostic tools is our first line of defense for protecting communities from disease, please join the webinar by registering here:

March 1-5, 2020.  PITTCON Annual Conference 2020, Chicago, IL.  Dr. Mickey S. Urdea is an invited speaker “Grand Challenges: Creating a Sustainable Market for Your Sensor Technologies: 28 Case Studies” at the PITTCON Annual Conference 2020 “Thinking Outside of The Box: Analytical Approaches Towards the Grand Challenges.” PITTCON is the world’s leading annual conference and exposition on laboratory science attracting 16,000 attendees from industry, academia and government from over 90 countries worldwide. From laboratory scientists, academicians to researchers in molecular and biological sciences, the PITTCON, a non-profit organization has been a pioneer in providing educational and scientific assistance to individuals who wish to carve a niche for themselves in this world of constant change to excel and provide best services. PITTCON not only covers analytical chemistry and spectroscopy, but also showcases developments made in the field of food safety, environmental sciences, bioterrorism and pharmaceutical industry.

February 12-13, 2020.  National Center for Global Health and Medicine Toyko, Japan.  Dr. Mickey S. Urdea is an invited speaker “Critical Success Factors for Diagnostics Companies Competing in Low- and Middle-Income Markets” at the National Center for Global Health and Medicine Seminar. The National Center for Global Health and Medicine Seminar for Japanese manufacturers and suppliers of diagnostics, pharmaceuticals and vaccines aims to raise awareness among manufacturers and suppliers on WHO prequalification schemes and to build their capacity to deploy their products in resource-limited settings.


August 4-8, 2019.   Dr. Mickey S. Urdea and Mr. Richard M. Thayer will attend the 71st AACC Annual Scientific Meeting & Clinical Lab Expo in Anaheim, California. AACC provides an unparalleled opportunity to connect with global leaders in laboratory medicine and to discover cutting edge technology and learn about vital research in the field. AACC is the meeting place for global leaders in clinical chemistry, molecular diagnostics, mass spectrometry, translational medicine, lab management, and other areas of breaking science in laboratory medicine.

July 08-10,2019.  Dr. Mickey S. Urdea will attend and present at the 2019 IDRTalks (Infectious Disease Research and Response Network) at Colorado State University in Fort Collins, CO and speak on “Why Diagnostics Companies Fail: Lessons Learned.”

June 17-18, 2019.  Dr. Mickey S. Urdea will attend the 27th International Biodetection Technologies: Biothreat and Pathogen Detection Conference in Bethesda, Maryland. This internationally recognized meeting is for experts in detection and identification of biological threats. This conference addresses the key topics in pathogen detection and presents the latest R&D and technological innovations in ready-to-market systems. In addition, this meeting will focus on the latest strategies to overcoming the hurdles to the identification of global biological threats and translational gaps in bringing technologies from lab to field. Stimulating discussions, perspectives of end-users, high quality case studies will be featured and the opportunity to network with the leading experts in biodefense from around the globe will be provided.

March 11-13, 2019 Mr. Richard M. Thayer will attend the Digital Health: Sensors, Wearables and IoT program of the Molecular Diagnostics Strategy and Outlook Executive Summit, part of the Molecular Medicine Tri-Conference in San Francisco, California. Molecular diagnostics along with healthcare in general are undergoing technology-driven revolution. Novel detection assays and sensors, digital biomarkers and machine learning approaches have become key drivers for innovation in drug development and patient care. This channel will feature the latest technology breakthroughs as well as partnering, regulatory and reimbursement solutions for implementation into value-based patient-centered care.

March 4-7, 2019  Dr. Mickey S. Urdea will participate in the CROI Conference in Seattle, Washington. The annual Conference on Retroviruses and Opportunistic Infections (CROI) brings together top basic, translational, and clinical researchers from around the world to share the latest studies, important developments, and best research methods in the ongoing battle against HIV/AIDS and related infectious diseases. The CROI Foundation partners with the International Antiviral Society–USA (IAS–USA) for organization of the conference.

January 7 - 10, 2019.  Dr. Mickey S. Urdea and Mr. Rich Thayer will attend the 37th Annual J.P. Morgan Healthcare Conference in San Francisco, California. The JPM Healthcare Conference continues their tradition of hosting the largest and most informative healthcare investment symposium in the industry. In 2019, more than 450 companies, both public and private, are set to deliver presentations to more than 9,000 attendees.


July 29-August 2, 2018. Dr. Mickey S. Urdea and Mr. Richard M. Thayer will attend the 70th AACC 2018 Annual Meeting in Chicago, Illinois. The American Association for Clinical Chemistry (AACC) Annual Scientific Meeting & Clinical Lab Expo is the largest global scientific conference and tradeshow in the field of laboratory medicine and provides opportunities to connect with global leaders in clinical chemistry, molecular diagnostics, mass spectrometry, translational medicine, lab management, and other areas of breaking science in laboratory medicine; learn about cutting edge technology; and hear about important changes in the field.

May 15, 2018. Dr. Mickey S. Urdea, a diagnostics entrepreneur and founding partner at Halteres Associates, will present —Why Do Diagnostics Companies Fail?—to the QB3 & the Rosenman Institute at the University of California, San Francisco on May 15, 2018. Over the last decade, several diagnostics companies that initially appeared to be on a path to success ultimately failed. The Bill & Melinda Gates Foundation asked Halteres to study the phenomenon. Classifying 28 companies as "Successes," "Failures," and "Zombies," the firm found that key indicators of success or failure emerged as companies drove their concepts toward commercialization.

February 13-14, 2018. Mr. Richard M. Thayer will attend the Cambridge Healthtech Institute's Inaugural Healthcare IoT (Internet of Things) Conference in San Francisco, California. The healthcare industry is at the advent of a digital evolution, spurred by a growing community of web-enabled products and services including the Cloud, smart and connected devices, and a more health-conscious and tech-savvy population. Cambridge Healthtech Institute's Inaugural Healthcare Internet of Things aims to bring together the different constituents and stakeholders within the value chain to participate in interactive discussion panels and deliver cases studies and pilot programs that showcase the healthcare industry's collaborative efforts toward the adoption and implementation of IoT. If you are interested in catching up with Rich during this conference, please let us know.

February 11-16, 2018. Mr. Rich Thayer will attend the 25th CHI Molecular Medicine Tri-Conference in San Francisco, CA February 11-16, 2018. Since its debut in 1993, the annual Molecular Medicine Tri-Conference is considered the premiere event on molecular medicine and diagnostics and has become one of the world's leading international events in the field of drug discovery, development, and diagnostics. The Tri-Conference presents more than 500 speakers and unites an ecosystem of 3,700 innovative thinkers and thought leaders throughout biotech, pharma, and academia from around the world. If you are interested in catching up with Rich while he is at Tri-Con, please let us know.

January 8-11, 2018. Dr. Mickey S. Urdea and Mr. Rich Thayer will attend the 36th Annual J.P. Morgan Healthcare Conference in San Francisco, California January 8-11, 2018. Thirty five years ago, J.P. Morgan launched Wall Street's premier investor conference focused exclusively on companies defining the healthcare industry. Today, the JPM Healthcare Conference continues their tradition of hosting the largest and most informative healthcare investment symposium in the industry. In 2018, more than 400 companies, both public and private, are set to deliver presentations to more than 8,000 attendees. The conference provides a unique opportunity for investors to visit with so many inter-related industry leaders in one setting. If you are interested in catching up with Mickey and Rich while they are at JPM, please let us know.


December 4-9, 2017. Dr. Mickey S. Urdea will attend the 19th ICASA (International Conference on AIDS and STIs in Africa) in Abidjan, Cote D'Ivoire. Dr. Urdea will also present “Insights From Business Modeling of Infectious Disease Diagnostic Products From The Perspective of Manufacturers and Procurers” at a satellite symposium scheduled for December 3, 2017. The convening of the International Conference on AIDS and Sexually Transmitted Infections in Africa (ICASA 2017) is the premier gathering for those working in the field of HIV, as well as leaders, people living with HIV, and others committed to ending the epidemic. This is a tremendous opportunity for researchers from around the world to share the latest scientific advances in the field, learn from one another's expertise, and develop strategies for advancing all facets of collective efforts to treat and prevent HIV.

November 16-18, 2017. Dr. Mickey S. Urdea and Mr. Richard M. Thayer will attend the AMP 2017 Annual Meeting November 16-18, 2017 in Salt Lake City, Utah. The Association for Molecular Pathology (AMP) provides structure and leadership to the emerging field of molecular diagnostics. AMP is a not-for-profit scientific society that advances the clinical practice, science, and excellence of molecular and genomic laboratory medicine through education, innovation, and advocacy to enable highest quality health care.

July 30 - August 3, 2017. Dr. Mickey S. Urdea and Mr. Richard M. Thayer will attend the 69th AACC Annual Scientific Meeting & Clinical Lab Expo in San Diego, California. The American Association of Clinical Chemists (AACC) brings together the world of laboratory medicine to exchange best practices, learn about the latest biomedical science, and network with like-minded professionals from across the globe.

July 23-26, 2017. Dr. Mickey S. Urdea will attend the 9th IAS Conference on HIV Science in Paris, France. Organized by the International AIDS Society (IAS) in partnership with the ANRS (France Recherche Nord & Sud Sida-HIV Hèpatites), IAS 2017 will serve as the platform to showcase the key research of the year. This biennial gathering is the largest open scientific conference on HIV and AIDS related issues - bringing together a broad cross-section of more than 6,000 professionals from around the world to meet and examine the latest scientific developments in HIV-related research with a focus on moving science into practice and policy.

May 31 - June, 2017. Dr. Mickey S. Urdea and Dr. Laura T. Mazzola will present and coordinate workshops at the 1st South African HIV Self-Testing Symposium in Johannesburg, South Africa. This meeting is convened by the South African National Department of Health through secretariat assistance from the Wits Reproductive Health and HIV Institute and the Bill & Melinda Gates Foundation.

May 16 - 17, 2017. Rich Thayer is an invited speaker at “The Maloney Entrepreneur's Workshop: The Journey From Discovery to Reality” at Washington State University Pullman Campus College of Veterinary Medicine, Pullman, WA.

Dr. Mickey Urdea of Halteres Associates was quoted in an April 2017 Chemistry World article

March 30-31, 2017. Geneva Switzerland, WHO Headquarters — Dr. Mickey Urdea of Halteres Associates, participated in the “Joint WHO/UNITAID Consultation with Diagnostic Manufacturers on Global Demand Forecasts for Diagnostics”

February 19-24, 2017. San Francisco CA — 24th CHI Molecular Tri-Con 2017, Dr. Urdea spoke at the meeting.

February 14, 2017. Dr. Mickey Urdea of Halteres Associates, was a panelist on The Association for Pathology Informatics (API) and Sunquest Information Systems “Consumerism in Diagnostics: Retail Testing and the Future of Providers” Webcast session on February 14th at 2:00 pm (ET).

February 12, 2017. Dr. Mickey Urdea of Halteres Associates, attended the Bill & Melinda Gates Foundation convening on HIV Self-Testing on Sunday February 12, 2017.

February 12, 2017. Dr. Mickey Urdea of Halteres Associates, attended the UNITAID pre-CROI event, Partnership for ART Optimisation at the Washington State Convention Center.


November 10-12, 2016. Charlotte, NC — Association for Molecular Pathology (AMP) Annual meeting, Halteres attended

July 18-22, 2016. Durban, South Africa — 21st International AIDS Conference, Halteres attended

June 13-17, 2016. Montreal, Quebec — Global Health Diagnostics Course, McGill University, Halteres attended

March 6-11, 2016. San Francisco, CA — 23rd CHI Molecular Tri-Conference, Halteres hosted a “Point-of-Care Diagnostics” seminar

March 7, 2016. San Francisco, CA — UCSF Symposium, “Preparedness for the Zika Virus: A Public Health Emergency”, Halteres attended


November 9-10, 2015. Bethesda, MD — IEEE EMBS Strategic Conference on Point of Care Technologies for Precision Medicine. Halteres presenting at the “Point of Care Business Models and Future Trends” session.

July 29, 2015. Atlanta. GA — American Association of Clinical Chemistry (AACC) Annual Meeting & Clinical Lab Expo. Halteres presented at “Convergence of Global Point-of-Care Diagnostic Needs” symposium.

June 8, 2015. Geneva, Switzerland—Halteres participated in the WHO Global Consultation on Diagnostics Interoperability Standards Meeting

May 29, 2015. San Francisco, CA — Mickey Urdea awarded the UCSF 150th Anniversary Alumni Excellence Award. Dr. Urdea was one of 150 award recipients.

May 18-19, 2015. Geneva, Switzerland—Halteres participated in the Point-of-Care Diagnostics Evaluations: Partners Synergy Meeting (II), co-sponsored by UNITAID and WHO

April 21, 2015. San Francisco, CA — Halteres presented at the Ebola Innovation Summit: 21st Century Tools to Tackle Ebola and Improve Health.

March 28, 2015. Santa Clara, CA — Halteres attended EPPICon 2015. Dr. Urdea was a panel moderator for: Innovations in Devices/Diagnostics


November 2014. Jaipur, India—Halteres attended the CHAI Supplier/Buyer Summit

October 13-15, 2014. Barcelona, Spain—Halteres presented at the WHO Working Group on HIV Incidence Assays Meeting, Presentation: Use Cases for HIV Incidence Assays

June 23-25, 2014. Dar es Salaam, Tanzania—Halteres participated in the African Society of Medicine HIV Consultative Meeting

Feb 14, 2014. San Francisco, CA—Halteres presented at the Molecular Tri Conference “Point of Care Testing (POCT): The Time is Now” session. Presentation: Why emerging markets are driving advancements in POCT and how developed markets are likely to benefit

Scroll to Top